Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
作者： Brian Czito , Margaret A. Tempero , Noelle LoConte , Brian M. Wolpin , E. Gabriela Chiorean
关键词:
摘要: Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients' advanced disease at diagnosis. The NCCN Guidelines for Pancreatic Adenocarcinoma provides recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pancreatic cancer. Although survival rates remain relatively unchanged, newer modalities of treatment, including targeted therapies, provide hope for improving patient outcomes …
elsevier.com
sci-hub.st 参考文章(192)
Shanshan Song, Baosheng Wang, Xin Zhang, Liliang Hao, Xianliang Hu, Zhongxiang Li, Shaolong Sun, Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0134321
William R. Bamlet, Kari G. Chaffee, Ann L. Oberg, Gloria M. Petersen, Samuel O. Antwi, Elizabeth C. Eckert, Corinna V. Sabaque, Emma R. Leof, Kieran M. Hawthorne, Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancer. Cancer Causes & Control. ,vol. 26, pp. 1583- 1591 ,(2015) , 10.1007/S10552-015-0652-Y
Aimee L. Lucas, Laura E. Frado, Caroline Hwang, Sheila Kumar, Lauren G. Khanna, Elana J. Levinson, John A. Chabot, Wendy K. Chung, Harold Frucht, BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts. Cancer. ,vol. 120, pp. 1960- 1967 ,(2014) , 10.1002/CNCR.28662
Robert McWilliams, Kari Rabe, Michele R. Johnson, Mariza de Andrade, Lisa Boardman, Fergus J. Couch, Gloria Petersen, Germ Line Fanconi Anemia Complementation Group C Mutations and Pancreatic Cancer Cancer Research. ,vol. 65, pp. 383- 386 ,(2005)
Henry T. Lynch, Randall E. Brand, David Hogg, Carolyn A. Deters, Ramon M. Fusaro, Jane F. Lynch, Ling Liu, Joseph Knezetic, Norman J. Lassam, Michael Goggins, Scott Kern, Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: The familial atypical multiple mole melanoma-pancreatic carcinoma syndrome Cancer. ,vol. 94, pp. 84- 96 ,(2002) , 10.1002/CNCR.10159
S. A. Hahn, B. Greenhalf, I. Ellis, M. Sina-Frey, H. Rieder, B. Korte, B. Gerdes, R. Kress, A. Ziegler, J. A. Raeburn, D. Campra, R. Grutzmann, H. Rehder, M. Rothmund, W. Schmiegel, J. P. Neoptolemos, D. K. Bartsch, BRCA2 Germline Mutations in Familial Pancreatic Carcinoma Journal of the National Cancer Institute. ,vol. 95, pp. 214- 221 ,(2003) , 10.1093/JNCI/95.3.214
Antoni Ribas, Releasing the Brakes on Cancer Immunotherapy. The New England Journal of Medicine. ,vol. 373, pp. 1490- 1492 ,(2015) , 10.1056/NEJMP1510079
Ralph H Hruban, Michiel S van der Heijden, Charles J Yeo, Scott E Kern, Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Research. ,vol. 63, pp. 2585- 2588 ,(2003)
Akseli Hemminki, David Markie, Ian Tomlinson, Egle Avizienyte, Stina Roth, Anu Loukola, Graham Bignell, William Warren, Maria Aminoff, Pia Höglund, Heikki Järvinen, Paula Kristo, Katarina Pelin, Maaret Ridanpää, Reijo Salovaara, Tumi Toro, Walter Bodmer, Sylviane Olschwang, Anne S Olsen, Michael R Stratton, Albert De La Chapelle, Lauri A Aaltonen, None, A serine/threonine kinase gene defective in Peutz–Jeghers syndrome Nature. ,vol. 391, pp. 184- 187 ,(1998) , 10.1038/34432
Christie Eheman, S. Jane Henley, Rachel Ballard-Barbash, Eric J. Jacobs, Maria J. Schymura, Anne-Michelle Noone, Liping Pan, Robert N. Anderson, Janet E. Fulton, Betsy A. Kohler, Ahmedin Jemal, Elizabeth Ward, Marcus Plescia, Lynn A. G. Ries, Brenda K. Edwards, Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer. ,vol. 118, pp. 2338- 2366 ,(2012) , 10.1002/CNCR.27514